Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Multi-state study of Enterobacteriaceae harboring extended-spectrum beta-lactamase and carbapenemase genes in U.S. drinking water.

Tanner WD, VanDerslice JA, Goel RK, Leecaster MK, Fisher MA, Olstadt J, Gurley CM, Morris AG, Seely KA, Chapman L, Korando M, Shabazz KA, Stadsholt A, VanDeVelde J, Braun-Howland E, Minihane C, Higgins PJ, Deras M, Jaber O, Jette D, Gundlapalli AV.

Sci Rep. 2019 Mar 8;9(1):3938. doi: 10.1038/s41598-019-40420-0.

2.

Altered metabolism of synthetic cannabinoid JWH-018 by human cytochrome P450 2C9 and variants.

Patton AL, Seely KA, Yarbrough AL, Fantegrossi W, James LP, McCain KR, Fujiwara R, Prather PL, Moran JH, Radominska-Pandya A.

Biochem Biophys Res Commun. 2018 Apr 6;498(3):597-602. doi: 10.1016/j.bbrc.2018.03.028. Epub 2018 Mar 10.

3.

A High Throughput Method for Measuring Polycyclic Aromatic Hydrocarbons in Seafood Using QuEChERS Extraction and SBSE.

Pfannkoch EA, Stuff JR, Whitecavage JA, Blevins JM, Seely KA, Moran JH.

Int J Anal Chem. 2015;2015:359629. doi: 10.1155/2015/359629. Epub 2015 Mar 19.

4.

Metabolism of classical cannabinoids and the synthetic cannabinoid JWH-018.

Su MK, Seely KA, Moran JH, Hoffman RS.

Clin Pharmacol Ther. 2015 Jun;97(6):562-4. doi: 10.1002/cpt.114. Epub 2015 Apr 17. Review.

PMID:
25788107
5.

Quantitative measurement of acetyl fentanyl and acetyl norfentanyl in human urine by LC-MS/MS.

Patton AL, Seely KA, Pulla S, Rusch NJ, Moran CL, Fantegrossi WE, Knight LD, Marraffa JM, Kennedy PD, James LP, Endres GW, Moran JH.

Anal Chem. 2014 Feb 4;86(3):1760-6. doi: 10.1021/ac4036197. Epub 2014 Jan 15.

PMID:
24354295
6.

Forensic investigation of K2, Spice, and "bath salt" commercial preparations: a three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds.

Seely KA, Patton AL, Moran CL, Womack ML, Prather PL, Fantegrossi WE, Radominska-Pandya A, Endres GW, Channell KB, Smith NH, McCain KR, James LP, Moran JH.

Forensic Sci Int. 2013 Dec 10;233(1-3):416-22. doi: 10.1016/j.forsciint.2013.10.002. Epub 2013 Oct 14.

PMID:
24314548
7.

Targeted metabolomic approach for assessing human synthetic cannabinoid exposure and pharmacology.

Patton AL, Seely KA, Chimalakonda KC, Tran JP, Trass M, Miranda A, Fantegrossi WE, Kennedy PD, Dobrowolski P, Radominska-Pandya A, McCain KR, James LP, Endres GW, Moran JH.

Anal Chem. 2013 Oct 1;85(19):9390-9. doi: 10.1021/ac4024704. Epub 2013 Sep 12.

PMID:
23987522
8.

Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands.

Chimalakonda KC, Seely KA, Bratton SM, Brents LK, Moran CL, Endres GW, James LP, Hollenberg PF, Prather PL, Radominska-Pandya A, Moran JH.

Drug Metab Dispos. 2012 Nov;40(11):2174-84. doi: 10.1124/dmd.112.047530. Epub 2012 Aug 17.

9.

AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies.

Seely KA, Brents LK, Franks LN, Rajasekaran M, Zimmerman SM, Fantegrossi WE, Prather PL.

Neuropharmacology. 2012 Oct;63(5):905-15. doi: 10.1016/j.neuropharm.2012.06.046. Epub 2012 Jul 4.

10.

Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids.

Seely KA, Lapoint J, Moran JH, Fattore L.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):234-43. doi: 10.1016/j.pnpbp.2012.04.017. Epub 2012 Apr 26. Review.

11.

A major glucuronidated metabolite of JWH-018 is a neutral antagonist at CB1 receptors.

Seely KA, Brents LK, Radominska-Pandya A, Endres GW, Keyes GS, Moran JH, Prather PL.

Chem Res Toxicol. 2012 Apr 16;25(4):825-7. doi: 10.1021/tx3000472. Epub 2012 Mar 15.

12.

Development of oxidative stress in the peritubular capillary microenvironment mediates sepsis-induced renal microcirculatory failure and acute kidney injury.

Wang Z, Holthoff JH, Seely KA, Pathak E, Spencer HJ 3rd, Gokden N, Mayeux PR.

Am J Pathol. 2012 Feb;180(2):505-16. doi: 10.1016/j.ajpath.2011.10.011. Epub 2011 Nov 24.

13.

Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury.

Holthoff JH, Wang Z, Seely KA, Gokden N, Mayeux PR.

Kidney Int. 2012 Feb;81(4):370-8. doi: 10.1038/ki.2011.347. Epub 2011 Oct 5.

14.

Natural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors.

Brents LK, Medina-Bolivar F, Seely KA, Nair V, Bratton SM, Nopo-Olazabal L, Patel RY, Liu H, Doerksen RJ, Prather PL, Radominska-Pandya A.

Xenobiotica. 2012 Feb;42(2):139-56. doi: 10.3109/00498254.2011.609570. Epub 2011 Oct 4.

15.

Hemodynamic changes in the kidney in a pediatric rat model of sepsis-induced acute kidney injury.

Seely KA, Holthoff JH, Burns ST, Wang Z, Thakali KM, Gokden N, Rhee SW, Mayeux PR.

Am J Physiol Renal Physiol. 2011 Jul;301(1):F209-17. doi: 10.1152/ajprenal.00687.2010. Epub 2011 Apr 20.

16.

Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?

Seely KA, Prather PL, James LP, Moran JH.

Mol Interv. 2011 Feb;11(1):36-51. doi: 10.1124/mi.11.1.6. Review.

17.

Notice of retraction.

Prather PL, Seely KA, Levi MS.

J Pharmacol Exp Ther. 2009 Dec;331(3):1147. No abstract available.

PMID:
19940110
18.
19.

The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset.

Shoemaker JL, Seely KA, Reed RL, Crow JP, Prather PL.

J Neurochem. 2007 Apr;101(1):87-98. Epub 2007 Jan 4.

Supplemental Content

Loading ...
Support Center